Kingsview Wealth Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-9,326
| Closed | -$387K | – | 985 |
|
|
2023
Q2 | $387K | Sell |
9,326
-1,477
| -14% | -$61.3K | 0.02% | 659 |
|
|
2023
Q1 | $650K | Buy |
10,803
+243
| +2% | +$14.6K | 0.03% | 505 |
|
|
2022
Q4 | $775K | Sell |
10,560
-97
| -0.9% | -$7.12K | 0.03% | 403 |
|
|
2022
Q3 | $810K | Sell |
10,657
-85
| -0.8% | -$6.46K | 0.04% | 379 |
|
|
2022
Q2 | $747K | Sell |
10,742
-930
| -8% | -$64.7K | 0.04% | 443 |
|
|
2022
Q1 | $967K | Buy |
11,672
+513
| +5% | +$42.5K | 0.04% | 404 |
|
|
2021
Q4 | $838K | Sell |
11,159
-764
| -6% | -$57.4K | 0.03% | 445 |
|
|
2021
Q3 | $1.39M | Buy |
11,923
+102
| +0.9% | +$11.8K | 0.07% | 294 |
|
|
2021
Q2 | $2.24M | Sell |
11,821
-38
| -0.3% | -$7.21K | 0.11% | 201 |
|
|
2021
Q1 | $1.58M | Sell |
11,859
-1,533
| -11% | -$204K | 0.09% | 231 |
|
|
2020
Q4 | $2.32M | Buy |
13,392
+653
| +5% | +$113K | 0.17% | 139 |
|
|
2020
Q3 | $1.42M | Sell |
12,739
-850
| -6% | -$94.6K | 0.13% | 170 |
|
|
2020
Q2 | $806K | Sell |
13,589
-5,878
| -30% | -$349K | 0.08% | 242 |
|
|
2020
Q1 | $1.31M | Buy |
19,467
+4,138
| +27% | +$279K | 0.18% | 145 |
|
|
2019
Q4 | $1.29M | Buy |
15,329
+1,344
| +10% | +$113K | 0.16% | 164 |
|
|
2019
Q3 | $1.05M | Sell |
13,985
-930
| -6% | -$69.6K | 0.16% | 155 |
|
|
2019
Q2 | $943K | Sell |
14,915
-285
| -2% | -$18K | 0.16% | 159 |
|
|
2019
Q1 | $732K | Buy |
+15,200
| New | +$732K | 0.11% | 215 |
|